Viral pharyngitis

Viral pharyngitis is caused by a virus. Antibiotics are not used to treat viral pharyngitis. Medication is given to treat the symptoms of viral pharyngitis, but not to impede or kill the virus. Acetaminophen or ibuprofen is given to reduce body temperature and ease discomfort. Saline gargles, lozenges, and increased fluid help soothe the throat. 

Antibiotics are not used to treat viral pharyngitis because pharyngitis is caused by a virus. 

Group A streptococcal pharyngitis is difficult to differentiate from viral pharyngitis based on history and clinical findings. However,... 

Pharyngitis is caused by a virus (viral pharyngitis) or by bacteria (bacteria pharyngitis) such as the beta-hemolytic streptococci. Patients know this as strep throat. A throat culture is taken to mle out beta-hemolytic streptococcal infection. Sometimes patients experience acute pharyngitis along with other upper respiratory tract disease such as a cold, rhinitis, or acute sinusitis. 

Patients who have a viral pharyngitis are given medications that treat the symptoms rather than attacking the underlying vims. Acetaminophen or ibupro-fen is given to reduce the patient s temperature and discomfort. Saline gargles, lozenges, and increased fluid are usually helpful to soothe the sore throat. 

Patients who have bacterial pharyngitis are given antibiotics to destroy the beta-hemolytic streptococci bacteria. However, antibiotics are only prescribed if the result of the throat culture is positive for bacteria. Patients are also given the same treatments for viral pharyngitis to address the symptoms of pharyngitis. 

Infection, either viral or bacterial, is the most common of all pathological processes in the pharyngeal areas. While antibiotics are commonly used to fight bacterial infections, viral infections should not be treated with antibiotics. Osteopathic manipulation is helpful to assist in the treatment of both bacterial and viral pharyngeal infections. 

The most common adverse effect with omalizumab is injection-site reaction, reported in 45% of patients in clinical trials. Other adverse effects include viral and upper respiratory tract infections, sinusitis, headache, and pharyngitis. Rare cases of malignant neoplasms and anaphylaxis were reported during clinical trials of omalizumab in asthma. Patients should be monitored for at least 2 hours following the injection so that anaphylaxis and/or injection-site reactions may be managed.25... 

Upper respiratory tract infection (URI) is a term that refers to various upper airway infections, including otitis media, sinusitis, pharyngitis, and rhinitis. Most URIs are viral and often selflimited. Over 1 billion viral URIs occur annually in the United States, resulting in millions of physician office visits each year.1 Excessive antibiotic use for URIs has contributed to the significant development of bacterial resistance. Guidelines have been established to reduce inappropriate antibiotic use for viral URIs.2 This chapter will focus on acute otitis media, sinusitis, and pharyngitis because they are frequently caused by bacteria and require appropriate antibiotic therapy to minimize complications. 

Assess the patient s signs and symptoms. Are they consistent with streptococcal pharyngitis Are symptoms of viral infection present ... 

Clinical presentations of primary HIV infection vary, but patients often have a viral syndrome or mononucleosis-like illness with fever, pharyngitis, and adenopathy (Table 40-3). Symptoms may last for 2 weeks. 

Pharyngitis is an acute infection of the oropharynx or nasopharynx that results in 1% to 2% of all outpatient visits. While viral causes are most common, Group A /J-hemolytic Streptococcus, or Streptococcus pyogenes, is the primary bacterial cause. 

Beclomethasone - Adverse reactions occurring in 3% or more of patients include headache nasal congestion dysmenorrhea dyspepsia rhinitis pharyngitis coughing upper respiratory tract infection viral infections ... 

Asthma Adverse reactions occurring in more than 3% of patients include headache and influenza. In children 6 to 14 years of age, the following events occurred with a frequency of 2% Diarrhea, laryngitis, pharyngitis, nausea, otitis, sinusitis, viral infections. In children 2 to 5 years of age the following events occurred with a frequency of 2% Rhinorrhea, otitis, ear pain, bronchitis, leg pain, thirst, sneezing. 

Injection site ecchymosis, redness, warmth, stinging, and urticaria viral infections sinusitis headache pharyngitis Occasional (8%-3%)... 

Syncope, vomiting, fatigue, viral infection, dyspepsia, diaphoresis, asthenia, orthostatic hypotension, abdominal discomfort, pharyngitis, abnormal vision, dry mouth, hypertension, hallucinations, confusion Rare (less than 4%)... 

Viral infection and upper respiratory tract infection (cough, pharyngitis, sinusitis, rhinitis) occur rarely. 

Clinical presentations of primary HIV infection vary, but patients often have a viral syndrome or mononucleosis-like illness with fever, pharyngitis, and adenopathy (Table 40-3). Symptoms may last for 2 weeks. Probability of progression to acquired immune deficiency syndrome (AIDS) is related to RNA viral load in one study, 5-year progression rates to AIDS were 8% and 62% for RNA copies per mElfliter of less than 4,530 and greater than 36,270, respectively. The mortality rates were 5% and 49%, respectively. 

Acute smallpox symptoms resemble those of other acute viral infections such as influenza. After an incubation period of 12-14 days (range 7-17 days), smallpox begins with a 2-4 day nonspecific prodrome of fever, myalgias, headache, and backache. Severe abdominal pain, nausea, vomiting, prostration, and delirium may be present. Patients are not infectious until the end of the prodrome (25), when a maculopapular rash begins on the oral and pharyngeal mucosa, face and forearms, and spreads to the trunk and legs. 

Viral implantation into oropharynx/respiratory tract spreads to regional lymph nodes viremia with virus multiplication in spleen, bone marrow, lymph nodes locates in leukocytes, small dermal blood vessels, and submucosal oral and pharyngeal cells... 

Streptococcal pharyngitis, 218-221 Sulfuryl fluoride poisoning, 399-402 Tularemia, 227-231 Viral rhinitis, 257-260... 

Pharyngitis is an acute infection of the oropharynx or nasopharynx. It results in 1% to 2% of all outpatient visits. While viral causes are most common, group A /3 -hemolytic Streptococcus, or S. pyogenes, is the primary bacterial cause and is the focus of this section. In the pediatric population, group A Streptococcus, or strep throat, causes 15% to 30% of cases of pharyngitis. In adults, it is the cause of 5% to 15% of all symptomatic episodes of pharyngitis. ... 

Smallpox Assumed low 10-100 organisms Pharyngeal swab, scab material ELISA, PCR, viral isolation Airborne Precautions... 

Poliovirus vaccine, inactivated, is a viral vaccine that induces protective antipoliovirus antibodies, reducing pharyngeal excretion of poliovirus types 1, 2, and 3. 

Acute abdominal pain is a common complaint in the pediatric age group. A total of 10% of school-age children have recurrent abdominal pain and in only 10% of these children can etiology be detected. The majority of these children have self-limited disease. The most common associated conditions include upper respiratory tract infection, pharyngitis, viral syndrome, gastroenteritis, and constipation (Henderson et al. 1992). Therefore, it is uncommon for the underlying condition in these children to require surgical intervention. 

A critical mechanism of action of n-3 polyunsaturated fatty acids is suspected to be a reduction in the endothelial production of IL-6 in response to naturally acquired viral infections. Increasing tissue concentrations of EPA and DH A markedly reduced the production of IL-6 from macrophages and endothelial cells in clinical trials and in cultured cells. In clinical intervention trials, dietary n-3 fatty acid supplementation suppressed the production of serum IL-6 in human subjects (13). In another set of normal subjects, IL-6 production was suppressed by 43% after supplementation with fish oil (14). IL-6 production was reduced by 54%, and clinical improvements were noted among patients with rheumatoid arthritis after supplementation with EPA and DHA (15). The role of EPA and DHA in reducing endothelial activation is complex and was reviewed recently by De Caterina et al. (16). These n-3 fatty acids may reduce naso-pharyngeal endothelial cell activation in response to viral adhesions, thereby reducing the severity of the illness and lessening the days of absence from school in the ill cohort. 

Parainfluenza Viral disease characterized by nasal inflammation, pharyngitis. Bronchitis, and sometimes pneumonia, mainly in children. 

---